Clinical trial
Effect of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss With Immunological Causes
NCT03174951 is registered in ClinicalTrials.gov with Tabriz University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss With Immunological Causes
- Lead sponsor
- Tabriz University of Medical Sciences
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 20, 2016
- Completion date
- June 20, 2017
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent pregnancy loss